Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer

被引:3
|
作者
Conces, Madison L. [1 ]
Mahipal, Amit [1 ]
机构
[1] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Cleveland, OH 44106 USA
关键词
rectal cancer; neoadjuvant therapy; chemotherapy; TOTAL MESORECTAL EXCISION; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; COURSE PREOPERATIVE RADIOTHERAPY; CLINICAL COMPLETE RESPONDERS; MEDIAN FOLLOW-UP; QUALITY-OF-LIFE; COLORECTAL-CANCER; INTERNATIONAL WATCH; SEXUAL DYSFUNCTION; RANDOMIZED-TRIAL;
D O I
10.3390/curroncol31010024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Local and metastatic recurrence are primary concerns following the treatment of locally advanced rectal cancer (LARC). Chemoradiation (CRT) can reduce the local recurrence rates and has subsequently moved to the neoadjuvant setting from the adjuvant setting. Pathological complete response (pCR) rates have also been noted to be greater in patients treated with neoadjuvant CRT prior to surgery. The standard approach to treating LARC would often involve CRT followed by surgery and optional adjuvant chemotherapy and remained the treatment paradigm for almost two decades. However, patients were often unable to complete adjuvant chemotherapy due to a decreased tolerance of chemotherapy following surgery, which led to upfront treatment with both CRT and chemotherapy, and total neoadjuvant therapy, or TNT, was created. The efficacy outcomes of local recurrence, disease-free survival, and pCR have improved in patients receiving TNT compared to the standard approach. Additionally, more recent data suggest a possible improvement in overall survival as well. Patients with a complete clinical response following TNT have the opportunity for watch-and-wait surveillance, allowing some patients to undergo organ preservation. Here, we discuss the clinical trials and studies that led to the adoption of TNT as the standard of care for LARC, with the possibility of watch-and-wait surveillance for patients achieving complete responses. We also review the possibility of overtreating some patients with LARC.
引用
收藏
页码:366 / 382
页数:17
相关论文
共 50 条
  • [31] Why is neoadjuvant chemoradiation therapy underused for locally advanced rectal cancer?
    Molinari, Chiara
    Passardi, Alessandro
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (12) : 1317 - 1319
  • [32] Total neoadjuvant therapy approach for the treatment of locally advanced rectal cancer. Where do we stand?
    Romero Zoghbi, Sigfredo Elias
    Martin, Margarita Martin
    Garcia, Juan Carlos
    Valero, Mireia
    Rincon, Diego
    Pena Huertas, Marina
    Fusco, Juan Pablo
    Lopez, Escarlata
    Zafra, Juan
    Fernandez Luengas, David
    Campos, Fernando Lopez
    Counago, Felipe
    ONCOLOGY, 2024, 102 (07) : 646 - 657
  • [33] Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!
    Ozer, Leyla
    Yildiz, Ibrahim
    Bayoglu, Vedat
    Bozkurt, Mustafa
    Esen, Eren
    Remzi, Feza H.
    Gogenur, Ismail
    Aytac, Erman
    COLORECTAL DISEASE, 2021, 23 (07) : 1662 - 1669
  • [34] Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer
    Sada, Yvonne H.
    Cao, Hop S. Tran
    Chang, George J.
    Artinyan, Avo
    Musher, Benjamin L.
    Smaglo, Brandon G.
    Massarweh, Nader N.
    JOURNAL OF SURGICAL RESEARCH, 2018, 226 : 15 - 23
  • [35] Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design
    Rana, Nitesh
    Chakravarthy, A. Bapsi
    Kachnic, Lisa A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (02)
  • [36] Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: PRODIGE 23 Trial
    Weiser, Martin R.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1493 - 1495
  • [37] Organ Function Preservation in Locally Advanced Low Rectal Cancer Through Total Neoadjuvant Therapy: A Case Report and Literature Review
    Liu, Fengyuan
    Yu, Li
    Zhao, Yuanyuan
    Li, Guoliang
    He, Xinjia
    CANCER MANAGEMENT AND RESEARCH, 2025, 17 : 121 - 129
  • [38] Total Neoadjuvant Therapy: A Shifting Paradigm in Locally Advanced Rectal Cancer Management
    Franke, Aaron J.
    Parekh, Hiral
    Starr, Jason S.
    Tan, Sanda A.
    Iqbal, Atif
    George, Thomas J., Jr.
    CLINICAL COLORECTAL CANCER, 2018, 17 (01) : 1 - 12
  • [39] Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Insights from the Western Australian Context
    Oey, Oliver
    Lin, Chak Pan
    Khattak, Muhammad Adnan
    Ferguson, Thomas
    Theophilus, Mary
    Tiong, Siaw Sze
    Ali, Sayed
    Khan, Yasir
    DISEASES, 2024, 12 (10)
  • [40] Efficacy and safety of total neoadjuvant therapy in locally advanced rectal cancer: a meta-analysis
    Xiong, Kai
    Bao, Tiantian
    Cao, Yibo
    Hu, Wenting
    Deng, Jia
    Chen, Jiang
    Xiao, Tianbao
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2023, 38 (01)